Delivery Order SPE2DB24D2011-SPE2DB25FBRFB
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,056.98 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product REXULTI 1 MG TABLET 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
This is a $10,397.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 3 MG TABLET 30S, a prescription medication, with a performance period ending on July 9, 2025. The contract is not set-aside and was awarded on July 8, 2025. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,964.10 firm fixed-price contract is for the delivery of the pharmaceutical product REXULTI 0.25 MG TABLET 30S. The contract has a performance period ending on July 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This $36,630.61 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of the pharmaceutical product REXULTI 1 MG TABLET 30S, with a performance period through January 21, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $6,945.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,123.62 firm fixed-price contract is for the delivery of REXULTI 3 MG TABLET 30S, with a performance period through May 19, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order for $1,845.10 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a prescription medication, with a performance period ending on July 8, 2025. The contract is not set aside and is a Firm Fixed Price type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This $5,627.36 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The award is for the supply of REXULTI 3 MG TABLET 30S, a brand name pharmaceutical product, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, as the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,058.93 contract is for the supply of REXULTI 0.5 MG TABLET 30S, a prescription medication, with a period of performance through July 11, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a firm fixed-price delivery order for $1,183.56 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REXULTI 1 MG TABLET 30S. The award has an ultimate completion date of March 28, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...